Disease Model Details HIV Therapies
Posted on: Tuesday, 6 June 2006, 15:00 CDT
U.S. government scientists say increasingly effective HIV therapies have provided 3 million years of total extended life to Americans with AIDS since 1989.
Drs. Rochelle Walensky, Kenneth Freedberg and colleagues at the National Institute of Allergy and Infectious Diseases also estimate drugs to prevent mother-to-child transmission of HIV have averted 2,900 infant infections, saving an additional 137,000 years of life.
The disease model used by the scientists suggests a person initiating HIV therapy in 2003 could expect to live more than 13 years longer than if he or she had been diagnosed in 1988.
As new HIV therapies have come into the clinic, we have witnessed the transformation of HIV/AIDS from a rapidly fatal disease into a controllable condition, said NIAID Director Dr. Anthony Fauci. Although the rate of new infections in this country remains unacceptably high, for many people HIV infection is no longer the death sentence it once was.
The researchers used a computer model developed by Freedberg and colleagues that incorporates literature-based data of clinical measures to simulate HIV disease progression both with and without treatment.
The study has been made available online by The Journal of Infectious Diseases.
Source: United Press International
Related Articles
- Genetic Immunity(R) Announces First Patient Dosed In Phase II Trial With DermaVir Patch For HIV Disease
- Fungal Infection Host Protein Found
- National HIV Testing Day: Tomorrow, Somebody Will Test Positive for the HIV Virus. Local Health Officials Want That Person and All Others Who Face the Prospect of Developing AIDS to Know the Disease is Now Treatable ? but the First Step is Getting Tested.
- An Emerging Severe Leukoencephalopathy: is It Due to HIV Disease or Highly Active Antiretroviral Therapy?
- Budget Impact of Medicaid Section 1115 Demonstrations for Early HIV Treatment
- Coping Modes With HIV Disease Predict Loss From HIV Study Cohort
- Clinical Profile of HIV in India
- HAART & the Molecular Biology of AIDS Dementia Complex
- New Program Offers Immediate Access to FUZEON(R) for Patients In Expanded Access Programs of Investigational HIV Therapies
 |
 |
User Comments (0)
RSS Feeds